Pfizer Inc.
PFE
주식 순위
#121
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
주가
$29.55
마지막 동기화: 2026-10-16
시가총액
$168.40B
변동 (1일)
0.37%
변동 (1년)
20.54%
국가
US
거래 Pfizer Inc. (PFE)
카테고리
Healthcare
Pfizer Inc. (PFE)의 영업이익률
October 2026 기준 영업이익률 TTM: 25.08%
Pfizer Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 25.08%입니다. 2024년 말 기준 영업이익률은 25.91%였습니다.
Pfizer Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 25.08% | 1.66% |
| 2025 | 24.67% | -4.79% |
| 2024 | 25.91% | 191.45% |
| 2023 | 8.89% | -76.25% |
| 2022 | 37.43% | 46.33% |
| 2021 | 25.58% | 17.29% |
| 2020 | 21.81% | 19.57% |
| 2019 | 18.24% | -36.00% |
| 2018 | 28.50% | 4.05% |
| 2017 | 27.39% | 1.37% |
| 2016 | 27.02% | -0.73% |
| 2015 | 27.22% | -3.75% |
| 2014 | 28.28% | -13.62% |
| 2013 | 32.74% | -0.79% |
| 2012 | 33.00% | 9.56% |
| 2011 | 30.12% | 13.92% |
| 2010 | 26.44% | -17.40% |
| 2009 | 32.01% | -7.00% |
| 2008 | 34.42% | 19.72% |
| 2007 | 28.75% | -7.85% |
| 2006 | 31.20% | 1.79% |
| 2005 | 30.65% | -5.81% |
| 2004 | 32.54% | 36.15% |
| 2003 | 23.90% | -36.99% |
| 2002 | 37.93% | 11.49% |
| 2001 | 34.02% | 16.03% |
| 2000 | 29.32% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 49.72% | -98.02% |
US
|
|
| 25.70% | -98.98% |
US
|
|
| 29.32% | -98.83% |
US
|
|
| 26.59% | -98.94% |
CH
|
|
| 16.65% | -99.34% |
US
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.